Evidence map›Paper›PMID 37325165›Full record

ArticleSAGE open medical case reports2023

Successful treatment of severe

Yan Xu, Zhaolin Li, Lamei Ouyang, Yinqing Su, Canmin Wang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yan XuDepartment of Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, People's Republic of China.
Zhaolin LiDepartment of Pulmonary and Critical Care Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.ORCID https://orcid.org/0000-0002-6222-0282
Lamei OuyangDepartment of Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, People's Republic of China.
Yinqing SuDepartment of Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, People's Republic of China.
Canmin WangDepartment of Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, People's Republic of China.
Guangdong Provincial People's Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

R-CHOP chemotherapy has been established as the first-line standard treatment for elderly patients diagnosed with diffuse large B-cell lymphoma. However, an increased risk of

Indexed as

anti-PJP treatmentdiffuse large B-cell lymphomaPneumocystis jiroveciipneumocystis pneumonia

Identifiers

PMID37325165
PMCPMC10265330
OpenAlexW4379259424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.